Prostate-specific antigen-producing cells in the bone marrow of a patient with early-stage prostate cancer

被引：6
|
作者：
DAmico, AV
Matelski, H
OLeary, M
Sussman, B
机构：
[1] ST LUKES HOSP, DEPT MED ONCOL, NEW BEDFORD, MA USA
[2] BRIGHAM & WOMENS HOSP, DEPT UROL, BOSTON, MA 02115 USA
[3] ST ANNES HOSP, DEPT RADIAT ONCOL, FALL RIVER, MA USA
来源：
UROLOGY | 1997年 / 49卷 / 02期
关键词：
D O I：
10.1016/S0090-4295(96)00443-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
This report describes a clinical case that supports the hypothesis that occult bone marrow disease may exist even in early-stage and low prostate-specific antigen (less than 10 ng/mL) prostate cancer. The concept of adding androgen suppression to definitive local therapy in these patients is discussed. Copyright 1997 by Elsevier Science Inc.
引用
收藏
页码：279 / 282
页数：4
相关论文
共 50 条
  • [31] Prostate-specific antigen bounce after curative brachytherapy for early-stage prostate cancer: A study of 274 African-Caribbean patients
    Leduc, N.
    Atallah, V.
    Creoff, M.
    Rabia, N.
    Taouil, T.
    Escarmant, P.
    Vinh-Hung, V.
    BRACHYTHERAPY, 2015, 14 (06) : 826 - 833
  • [32] Complexed prostate-specific antigen, and complext prostate-specific antigen indices for early detection of prostate cancer in men with total prostate-specific antigen between 2.0 and 4.0 ng/ml
    Reissigl, A
    Remzi, M
    Wiunig, C
    Zlotta, A
    Ravery, V
    Hammerer, P
    Dobronski, P
    Kaisary, A
    Marberger, M
    Djavan, B
    JOURNAL OF UROLOGY, 2003, 169 (04): : 426 - 427
  • [33] CANCER (PROSTATE-SPECIFIC ANTIGEN)
    CASTELLANI, WJ
    ANALYTICAL CHEMISTRY, 1995, 67 (12) : R399 - R403
  • [34] Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells
    Fujii, Y
    Kawakami, S
    Okada, Y
    Kageyama, Y
    Kihara, K
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 286 (06): : E927 - E931
  • [35] Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells
    Bindukumar, B.
    Schwartz, Stanley
    Aalinkeel, Ravikumar
    Mahajan, Supriya
    Lieberman, Alicia
    Chadha, Kailash
    PROSTATE, 2008, 68 (14): : 1531 - 1545
  • [36] Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer
    Abdalla, I
    Ray, P
    Ray, V
    Vaida, F
    Vijayakumar, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06): : 537 - 541
  • [37] Clinical use of prostate-specific antigen and prostate-specific antigen density in the staging of patients with cancer of the prostate
    Wolff, JM
    Boeckmann, W
    Effert, PJ
    Handt, S
    Jakse, G
    EUROPEAN UROLOGY, 1996, 30 (04) : 451 - 457
  • [38] The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer
    Partin, AW
    Carter, HB
    UROLOGIC CLINICS OF NORTH AMERICA, 1996, 23 (04) : 531 - +
  • [39] Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer
    Amoako, Yaw Ampem
    Hammond, Emmanuel
    Assasie-Gyimah, Awo
    Laryea, Dennis Odai
    Ankrah, Alfred
    Amoah, George
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2019, 18 (02) : 143 - 148
  • [40] Effect of Prostate-Specific Antigen on mouse bone metastasis from prostate cancer
    Hopmans, Sarah
    Cumming, Andrew
    Vukmirovic-Popovic, Snezana
    Singh, Gurmit
    Duivenvoorden, Wilhelmina
    CANCER RESEARCH, 2009, 69
12345